
Opinion|Videos|October 12, 2023
Integrating MRI and Ultrasound Fusion-Based Technology for Personalized Focal Therapy in Prostate Cancer
Author(s)Amir H. Lebastchi, MD
Dr. Amir H. Lebastchi elaborates on his approach to integrating MRI and ultrasound fusion-based technology for guiding treatment selection and tailoring therapy for patients with prostate cancer.
Advertisement
Episodes in this series

Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
MRI, myths, and precision: Stacy Loeb, MD, discusses modern prostate cancer screening
2
Theranostic therapies expand frontline use in prostate cancer
3
Health Canada approves testosterone undecanoate for hypogonadism
4
Aaron Hansen, MD, shares key findings from the theraPb trial in mCRPC
5





















